So, these findings suggest that genetically altering a bacterium candidate with inherent immunomodulatory capabilities (e.g., S. thermophilus CRL 807) by inserting a gene encoding an antioxidant enzyme improves its anti-inflammatory effects to express catalase and superoxide dismutase and is able to reduce colitis in a murine model [177]. The gene discussed is CAT; the disease is colitis.